一品红跌2.01%，成交额2.03亿元，主力资金净流入247.23万元

Core Viewpoint - Yipinhong's stock price has experienced significant fluctuations, with a year-to-date increase of 186.34% but a recent decline of 12.67% over the past five trading days [1] Financial Performance - For the period from January to September 2025, Yipinhong reported revenue of 814 million yuan, a year-on-year decrease of 34.35%, while the net profit attributable to shareholders was -136 million yuan, an increase of 44.80% year-on-year [2] Stock Market Activity - As of November 7, Yipinhong's stock price was 48.85 yuan per share, with a total market capitalization of 22.065 billion yuan. The stock has seen a trading volume of 203 million yuan and a turnover rate of 0.99% [1] - The stock has appeared on the "龙虎榜" (a list of stocks with significant trading activity) five times this year, with the most recent appearance on July 21, where it recorded a net purchase of 65.576 million yuan [1] Shareholder Information - As of October 31, Yipinhong had 20,700 shareholders, an increase of 9.42% from the previous period, with an average of 20,156 circulating shares per shareholder, a decrease of 8.61% [2] - Notable new institutional shareholders include Hong Kong Central Clearing Limited and Guangfa Healthcare Stock A, which are now among the top ten circulating shareholders [3] Business Overview - Yipinhong Pharmaceutical Group Co., Ltd. specializes in the research, production, and sales of its own pharmaceuticals, with a revenue composition of 61.12% from pediatric drugs, 22.71% from chronic disease medications, and 16.17% from other products [1] - The company is classified under the pharmaceutical and biological industry, specifically in chemical pharmaceuticals and formulations, and is involved in several concept sectors including AI medicine and vaccines [2] Dividend Information - Since its A-share listing, Yipinhong has distributed a total of 335 million yuan in dividends, with 151 million yuan distributed over the past three years [3]